Cerebral	cerebral	O	O	O	O
blood	blood	O	O	O	O
flow	flow	O	O	O	O
and	and	O	O	O	O
metabolism	metabolism	O	O	O	O
during	during	O	O	O	O
isoflurane-induced	isoflurane-induced	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
subjected	subjected	O	O	O	O
to	to	O	O	O	O
surgery	surgery	O	O	O	O
for	for	O	O	O	O
cerebral	cerebral	O	O	OTHERS	I
aneurysms	aneurysms	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Cerebral	cerebral	O	O	O	O
blood	blood	O	O	O	O
flow	flow	O	O	O	O
and	and	O	O	O	O
cerebral	cerebral	O	O	O	O
metabolic	metabolic	O	O	O	O
rate	rate	O	O	O	O
for	for	O	O	O	O
oxygen	oxygen	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
measured	measured	O	O	O	O
during	during	O	O	O	O
isoflurane-induced	isoflurane-induced	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
in	in	O	O	O	O
10	10	O	O	O	O
patients	patients	O	O	O	O
subjected	subjected	O	O	O	O
to	to	O	O	O	O
craniotomy	craniotomy	O	O	O	O
for	for	O	O	O	O
clipping	clipping	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
cerebral	cerebral	O	O	OTHERS	I
aneurysm	aneurysm	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Flow	flow	O	O	O	O
and	and	O	O	O	O
metabolism	metabolism	O	O	O	O
were	were	O	O	O	O
measured	measured	O	O	O	O
5	5	O	O	O	O
-	-	O	O	O	O
13	13	O	O	O	O
days	days	O	O	O	O
after	after	O	O	O	O
the	the	O	O	O	O
subarachnoid	subarachnoid	O	O	OTHERS	I
haemorrhage	haemorrhage	O	O	OTHERS	I
by	by	O	O	O	O
a	a	O	O	O	O
modification	modification	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
classical	classical	O	O	O	O
Kety-Schmidt	kety-schmidt	O	O	O	O
technique	technique	O	O	O	O
using	using	O	O	O	O
xenon-133	xenon-133	O	O	O	O
i.v	i.v	O	O	O	O
.	.	O	O	O	O

Anaesthesia	anaesthesia	O	O	O	O
was	was	O	O	O	O
maintained	maintained	O	O	O	O
with	with	O	O	O	O
an	an	O	O	O	O
inspired	inspired	O	O	O	O
isoflurane	isoflurane	CHEMICALS	O	OTHERS	I
concentration	concentration	O	O	O	O
of	of	O	O	O	O
0.75	0.75	O	O	O	O
%	%	O	O	O	O
(	(	O	O	O	O
plus	plus	O	O	O	O
67	67	O	O	O	O
%	%	O	O	O	O
nitrous	nitrous	CHEMICALS	O	OTHERS	I
oxide	oxide	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
oxygen	oxygen	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
during	during	O	O	O	O
which	which	O	O	O	O
CBF	cbf	O	O	O	O
and	and	O	O	O	O
CMRO2	cmro2	O	O	O	O
were	were	O	O	O	O
34.3	34.3	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
2.1	2.1	O	O	O	O
ml/100	ml/100	O	O	O	O
g	g	O	O	O	O
min-1	min-1	O	O	O	O
and	and	O	O	O	O
2.32	2.32	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
0.16	0.16	O	O	O	O
ml/100	ml/100	O	O	O	O
g	g	O	O	O	O
min-1	min-1	O	O	O	O
at	at	O	O	O	O
PaCO2	paco2	O	O	O	O
4.1	4.1	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
0.1	0.1	O	O	O	O
kPa	kpa	O	O	O	O
(	(	O	O	O	O
mean	mean	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
SEM	sem	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Controlled	controlled	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
to	to	O	O	O	O
an	an	O	O	O	O
average	average	O	O	O	O
MAP	map	O	O	OTHERS	I
of	of	O	O	O	O
50	50	O	O	O	O
-	-	O	O	O	O
55	55	O	O	O	O
mm	mm	O	O	OTHERS	I
Hg	hg	O	O	OTHERS	I
was	was	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
increasing	increasing	O	O	O	O
the	the	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
isoflurane	isoflurane	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
maintained	maintained	O	O	O	O
at	at	O	O	O	O
an	an	O	O	O	O
inspired	inspired	O	O	O	O
concentration	concentration	O	O	O	O
of	of	O	O	O	O
2.2	2.2	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
0.2	0.2	O	O	O	O
%	%	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
resulted	resulted	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
decrease	decrease	O	O	O	O
in	in	O	O	O	O
CMRO2	cmro2	O	O	O	O
(	(	O	O	O	O
to	to	O	O	O	O
1.73	1.73	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
0.16	0.16	O	O	O	O
ml/100	ml/100	O	O	O	O
g	g	O	O	O	O
min-1	min-1	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
while	while	O	O	O	O
CBF	cbf	O	O	O	O
was	was	O	O	O	O
unchanged	unchanged	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
the	the	O	O	O	O
clipping	clipping	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
aneurysm	aneurysm	O	DISEASE	OTHERS	I
the	the	O	O	O	O
isoflurane	isoflurane	CHEMICALS	O	OTHERS	I
concentration	concentration	O	O	O	O
was	was	O	O	O	O
reduced	reduced	O	O	O	O
to	to	O	O	O	O
0.75	0.75	O	O	O	O
%	%	O	O	O	O
.	.	O	O	O	O

There	there	O	O	O	O
was	was	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
CBF	cbf	O	O	O	O
,	,	O	O	O	O
although	although	O	O	O	O
CMRO2	cmro2	O	O	O	O
was	was	O	O	O	O
unchanged	unchanged	O	O	O	O
,	,	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
pre-hypotensive	pre-hypotensive	O	O	O	O
values	values	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
changes	changes	O	O	O	O
might	might	O	O	O	O
offer	offer	O	O	O	O
protection	protection	O	O	O	O
to	to	O	O	O	O
brain	brain	O	O	O	O
tissue	tissue	O	O	O	O
during	during	O	O	O	O
periods	periods	O	O	O	O
of	of	O	O	O	O
induced	induced	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

